Changes in plasma angiotensin-converting enzyme activity and noradrenaline responses to long-term nitric oxide inhibition vary depending on their basal values in chickens

Physiological Research

Volumn 49, Issue 1, 2000, Pages 175-182

  Aksulu, H E ^a   Bingol I ^b   Karatas, F ^b   Sagmanligil, H ^b   Ustundag B ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b NONE

Author keywords

Adrenaline; Angiotensin converting enzyme; Blood pressure; Chicken; N nitro L arginine; Noradrenaline

Indexed keywords

ADRENALIN; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ARGININE; BLOOD PRESSURE; CHICKENS; ENZYME INHIBITORS; EPINEPHRINE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; RENIN;

EID: 0033976282     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AKSULU HE, CELLEK S, TÜRKER RK: Cholesterol feeding attenuates endothelium-dependent relaxation response to acethylcholine in the main pulmonary artery of chickens. Eur J Pharmacol 129: 397-400, 1986.
2. AKSULU HE, BINGÖL I, KARATAŞ F, SAǦMANLIGIL H, ÜSTÜNDAǦ B: Changes in plasma angiotensin-converting enzyme activity (ACE) and noradrenaline responses to long-term nitric oxide inhibition vary depending on their basal values in chickens. Physiol Res 48: 27P, 1999.
3. ω-nitro-L-arginine decreases plasma renin (PRA) and angiotensin-converting enzyme (ACE) activities and plasma noradrenaline level without changing blood pressure in chickens. Physiol Res 48: 27P, 1999.
4. CLARKSON TB, MIDDLETON CC, PRICHARD RW, LOFLAND HB: Naturally-occurring atherosclerosis in birds. Ann NY Acad Sci 127: 685-705, 1965.
5. COHEN RA, WEISBROD RM: Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. Am J Physiol 254: H871-H878, 1988.
6. DE CHAMPLAIN J, KRAKOFF LR, AXELROD J: Catecholamine metabolism in experimental hypertension in the rat. Circ Res 20: 136-145, 1967.
7. EL-HALAWANI ME, WAIBEL PE, APPEL JR, GOOD AL, DUKE GE: Catecholamines in turkeys with high or low blood pressure: effects of tyrosine hydroxylase and ganglionic blocker. Can J Physiol Pharmacol 50: 697-702, 1972.
8. GARDINER SM, COMPTON AM, BENNETT T, PALMER RMJ, MONCADA S: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15: 486-492, 1990.
9. GREENBERG SS, DIECKE FP, REEVY K, TANAKA TP: Release of norephinephrine from adrenergic nerve endings of blood vessels mediated by endothelium-derived relaxing factor. Am J Hypertens 3: 211-218, 1990.
10. HABER E, KOERNER L, PAGE LB, KRIMAN B, PURNODE A: Application of radioimmunoassay for angiotensin 1 to the physiologic measurement of plasma renin activity in normal subjects. J Clin Endocrinol Metab 29: 1349-1355, 1969.
11. HALBRÜGGE T, LÜTSCH K, THYEN A, GRAEFE K-H: Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 344: 720-727, 1991.
12. HASEGAWA K, NISHIMURA H, KHOSLA MC: Angiotensin II-induced endothelium-dependent relaxation of fowl aorta. Am J Physiol 264: R903-R911, 1993.
13. HOLMQUIST B, BÜNNING P, RIORDAN JF: A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 95: 540-554, 1979.
14. KAMIMURA K, NISHIMURA H, BAILEY JR: Blockade of β-adrenoceptor in control of blood pressure in fowl. Am J Physiol 269: R914-R922, 1995.
15. LOUIS WJ, SPECTOR S, TABEI R, SJOERDSMA A : Synthesis and turnover of norepinephrinein the heart of the spontaneously hypertensive rat. Circ Res 24: 85-91, 1969.
16. LOUIS WJ, DOYLE AE, ANAVEKAR SN: Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin Sci Mol Med 48 (suppl 2): 229s-242s, 1975.
17. MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
18. NISHIMURA H, NAKAMURA Y, SUMNER RP, KHOSLA MC: Vasopressor and depressor actions of angiotensin in the anesthetized fowl. Am J Physiol 242: H314-H324, 1982.
19. PALMER RMJ, ASHTON DS, MONCADA S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
20. REES DD, PALMER RMJ, SCHULZ R, HODSON HF, MONCADA S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
21. STURKIE PD: Heart and circulation: anatomy, hemodynamics, blood pressure, blood flow. In: Avian Physiology. PD STURKIE ( ed), Springier, New York, 1986, pp 130-166.
22. THORIN E, ATKINSSON J: Modulation by endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery. Br J Pharmacol 111: 351-357, 1994.
23. G-nitro-L-arginine on the contraction of the dog temporal artery elicited by transmural stimulation of noradrenergic nerves. Naunyn-Schiedeberg's Arch Pharmacol 343: 221-224, 1991.